PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+5.51%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$16.1B
AUM Growth
+$727M
(+4.7%)
Cap. Flow
+$462M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
375
New
58
Increased
118
Reduced
105
Closed
56
Top Buys
| 1 |
Micron Technology
MU
|
+$173M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$142M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$141M |
| 4 |
Guardant Health
GH
|
+$106M |
| 5 |
Applied Materials
AMAT
|
+$102M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$158M |
| 2 |
Advanced Micro Devices
AMD
|
+$140M |
| 3 |
Amazon
AMZN
|
+$131M |
| 4 |
Humana
HUM
|
+$90.9M |
| 5 |
Axon Enterprise
AXON
|
+$86.1M |
Sector Composition
| 1 | Technology | 35.49% |
| 2 | Healthcare | 19.84% |
| 3 | Financials | 16.96% |
| 4 | Communication Services | 14.54% |
| 5 | Consumer Discretionary | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
RLI Corp
RLI
$6.14B
| $30.7M | 0.19% |
550,000
| – | – |
|
|
GBT
127
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $30.6M | 0.19% |
750,000
+250,000
| +50% | +$10.2M |
|
128
Addus HomeCare
ADUS
$2.03B
| $30.4M | 0.19% |
290,827
-126,116
| -30% | -$13.2M |
|
129
Wells Fargo
WFC
$261B
| $29.3M | 0.18% |
750,577
+558,243
| +290% | +$21.8M |
|
130
Alnylam Pharmaceuticals
ALNY
$61.1B
| $28M | 0.17% |
198,500
-3,500
| -2% | -$494K |
|
131
Fiserv
FI
$73B
| $27.8M | 0.17% |
233,701
-9,642
| -4% | -$1.15M |
|
|
DRNA
132
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $27.7M | 0.17% |
+1,084,813
| New | +$27.7M |
|
133
Affiliated Managers Group
AMG
$6.71B
| $26.2M | 0.16% |
175,483
| – | – |
|
134
KalVista Pharmaceuticals
KALV
$708M
| $25.9M | 0.16% |
+1,007,055
| New | +$25.9M |
|
135
United Rentals
URI
$60.4B
| $25.6M | 0.16% |
77,800
+10,446
| +16% | +$3.44M |
|
|
AVDL
136
Avadel Pharmaceuticals
AVDL
$1.5B
| $25.3M | 0.16% |
2,794,673
-233,032
| -8% | -$2.11M |
|
137
Altria Group
MO
$112B
| $24.7M | 0.15% |
482,060
+181,961
| +61% | +$9.31M |
|
138
BioNTech
BNTX
$23.3B
| $24.6M | 0.15% |
+225,000
| New | +$24.6M |
|
139
JPMorgan Chase
JPM
$844B
| $24.3M | 0.15% |
159,889
+24,214
| +18% | +$3.69M |
|
140
Canadian Natural Resources
CNQ
$64.9B
| $24.1M | 0.15% |
1,418,894
+655,106
| +86% | +$11.1M |
|
141
SS&C Technologies
SSNC
$21.8B
| $23.7M | 0.15% |
339,766
+78,672
| +30% | +$5.5M |
|
142
BlackLine
BL
$3.36B
| $23.6M | 0.15% |
217,421
+46,049
| +27% | +$4.99M |
|
143
Envista
NVST
$3.49B
| $23.3M | 0.14% |
570,202
-297,393
| -34% | -$12.1M |
|
144
Littelfuse
LFUS
$6.54B
| $23.1M | 0.14% |
87,295
-9,719
| -10% | -$2.57M |
|
145
Aflac
AFL
$58.4B
| $22.5M | 0.14% |
440,000
| – | – |
|
146
Enovis
ENOV
$1.81B
| $22.5M | 0.14% |
298,460
-152,402
| -34% | -$11.5M |
|
147
Bristol-Myers Squibb
BMY
$94B
| $22M | 0.14% |
348,843
+16,000
| +5% | +$1.01M |
|
148
Taylor Morrison
TMHC
$6.88B
| $21.7M | 0.13% |
703,955
-146,438
| -17% | -$4.51M |
|
149
Icon
ICLR
$13.6B
| $21.2M | 0.13% |
107,942
+53,829
| +99% | +$10.6M |
|
150
Ametek
AME
$43.9B
| $20.9M | 0.13% |
163,275
-37,335
| -19% | -$4.77M |
|